m6A-modified RIPK4 facilitates proliferation and cisplatin resistance in epithelial ovarian cancer. Yin X, Zhao S, Zhang M, Xing J, et al. Gynecol Oncol 2023;180:99-110.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yin X, Zhao S, Zhang M, Xing J, et al. m6A-modified RIPK4 facilitates proliferation and cisplatin resistance in epithelial ovarian cancer. Gynecol Oncol 2023;180:99-110.
PMID: 38086167